NURIX THERAPEUTICS, INC.: cash_and_restricted_cash

Value{"amount": 56410000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2020-02-29)
Statuscurrent
EntityNURIX THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-21-018713 · Open the official SEC filing →
Retrieved: 2026-08-19T15:43:20.797219+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001549595/cash-and-restricted-cash/2020-02-29 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4c15b210-3d60-4df2-a96d-e57e66a3ad44

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies